Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.

Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol (2013) 4.72

The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo. J Immunol (2011) 2.69

A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat Immunol (2013) 2.50

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. J Exp Med (2011) 1.77

Programmed death ligand 2 in cancer-induced immune suppression. Clin Dev Immunol (2012) 1.71

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med (2014) 1.59

Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1. Structure (2015) 1.27

Structure and interactions of the human programmed cell death 1 receptor. J Biol Chem (2013) 1.27

Labile disulfide bonds are common at the leucocyte cell surface. Open Biol (2011) 1.14

PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int Immunol (2010) 1.13

HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function. Proc Natl Acad Sci U S A (2013) 1.12

A dimeric structure of PD-L1: functional units or evolutionary relics? Protein Cell (2010) 1.11

Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6. J Exp Med (2011) 1.11

The complex role of B7 molecules in tumor immunology. Trends Mol Med (2008) 1.09

Sequence, structure, function, immunity: structural genomics of costimulation. Immunol Rev (2009) 1.08

Structures of PD-1 with its ligands: sideways and dancing cheek to cheek. Proc Natl Acad Sci U S A (2008) 1.00

Structural basis for recognition of cellular and viral ligands by NK cell receptors. Front Immunol (2014) 0.94

Structure and cancer immunotherapy of the B7 family member B7x. Cell Rep (2014) 0.93

Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site. Proc Natl Acad Sci U S A (2011) 0.92

Structure and T cell inhibition properties of B7 family member, B7-H3. Structure (2013) 0.90

PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. J Clin Invest (2013) 0.90

Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies. Biochim Biophys Acta (2015) 0.86

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy. Nat Commun (2016) 0.86

Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers. Mol Ther Nucleic Acids (2015) 0.85

Structural basis for blocking PD-1-mediated immune suppression by therapeutic antibody pembrolizumab. Cell Res (2016) 0.84

Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine. Mol Ther (2013) 0.82

Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells. Oncotarget (2016) 0.81

Targeting immune co-stimulatory effects of PD-L1 and PD-L2 might represent an effective therapeutic strategy in stroke. Front Cell Neurosci (2014) 0.81

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation. Front Immunol (2016) 0.80

An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. Nat Commun (2017) 0.80

Crystal clear: visualizing the intervention mechanism of the PD-1/PD-L1 interaction by two cancer therapeutic monoclonal antibodies. Protein Cell (2016) 0.78

Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3. J Biol Chem (2015) 0.78

The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3. Immunol Rev (2017) 0.77

Inhibitors of B7-CD28 costimulation in urologic malignancies. Immunotherapy (2009) 0.77

Up-regulation of Tim-3 on T cells during acute simian immunodeficiency virus infection and on antigen specific responders. AIDS (2015) 0.77

Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy. EBioMedicine (2017) 0.75

Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant. Structure (2016) 0.75

Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment. Oncotarget (2016) 0.75

In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network. J Biol Chem (2017) 0.75

Enhancement of PSMA-Directed CAR Adoptive Immunotherapy by PD-1/PD-L1 Blockade. Mol Ther Oncolytics (2016) 0.75

Prokaryotic expression of the extracellular domain of porcine programmed death 1 (PD-1) and its ligand PD-L1 and identification of the binding with peripheral blood mononuclear cells in vitro. Can J Vet Res (2017) 0.75

Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade. Cell Discov (2017) 0.75

Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8(+) T Cell Responses to Chronic Viral Infections and Cancer. Front Immunol (2017) 0.75

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med (2000) 19.81

The B7 family revisited. Annu Rev Immunol (2005) 13.51

Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity (1999) 12.36

PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol (2001) 12.26

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity (2007) 8.94

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol (2007) 7.60

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol (2004) 7.16

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol (1996) 6.79

PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol (2007) 6.24

Expression of programmed death 1 ligands by murine T cells and APC. J Immunol (2002) 5.78

Costimulation blockade with belatacept in renal transplantation. N Engl J Med (2005) 4.86

The PD-1-PD-L pathway in immunological tolerance. Trends Immunol (2006) 4.52

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant (2005) 4.05

PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A (2001) 3.32

Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med (2003) 2.66

The B7 family and cancer therapy: costimulation and coinhibition. Clin Cancer Res (2007) 2.54

Crystal structure of a soluble CD28-Fab complex. Nat Immunol (2005) 2.46

Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature (2001) 2.42

Structure and dimerization of a soluble form of B7-1. Immunity (2000) 2.33

Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature (2001) 2.21

The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci U S A (2008) 2.03

Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity (2004) 1.70

Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun (2003) 1.49

Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science (2000) 1.45

Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability. Proc Natl Acad Sci U S A (2007) 1.28

Structural mechanisms of costimulation. Nat Immunol (2002) 1.21

Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proc Natl Acad Sci U S A (2005) 1.15

Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature (2013) 5.75

Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin. Proc Natl Acad Sci U S A (2009) 4.88

Protein production and purification. Nat Methods (2008) 3.97

Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci U S A (2003) 3.75

Structure-based activity prediction for an enzyme of unknown function. Nature (2007) 3.65

Activated TCRs remain marked for internalization after dissociation from pMHC. Nat Immunol (2002) 3.01

Prediction and assignment of function for a divergent N-succinyl amino acid racemase. Nat Chem Biol (2007) 2.29

Evolution of enzymatic activities in the enolase superfamily: L-fuconate dehydratase from Xanthomonas campestris. Biochemistry (2006) 2.15

Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A (2010) 2.12

T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity (2007) 1.92

Structural genomics: a pipeline for providing structures for the biologist. Protein Sci (2002) 1.91

Discovery of a dipeptide epimerase enzymatic function guided by homology modeling and virtual screening. Structure (2008) 1.91

The Enzyme Function Initiative. Biochemistry (2011) 1.87

Structure of the actin crosslinking core of fimbrin. Structure (2004) 1.82

Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation. Biochemistry (2005) 1.73

Structural basis for the coevolution of a viral RNA-protein complex. Nat Struct Mol Biol (2007) 1.71

Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity (2004) 1.70

ZBP1 recognition of beta-actin zipcode induces RNA looping. Genes Dev (2010) 1.63

Neighboring group participation in the transition state of human purine nucleoside phosphorylase. Biochemistry (2007) 1.53

Structural effects of cofilin on longitudinal contacts in F-actin. J Mol Biol (2002) 1.50

T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. Proc Natl Acad Sci U S A (2005) 1.49

Functional classification of immune regulatory proteins. Structure (2013) 1.49

Functional annotation and three-dimensional structure of Dr0930 from Deinococcus radiodurans, a close relative of phosphotriesterase in the amidohydrolase superfamily. Biochemistry (2009) 1.47

Discovery of new enzymes and metabolic pathways by using structure and genome context. Nature (2013) 1.46

The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc Natl Acad Sci U S A (2008) 1.44

Identification of functional residues on Caenorhabditis elegans actin-interacting protein 1 (UNC-78) for disassembly of actin depolymerizing factor/cofilin-bound actin filaments. J Biol Chem (2004) 1.40

Structural underpinnings of nitrogen regulation by the prototypical nitrogen-responsive transcriptional factor NrpR. Structure (2010) 1.40

Divergent evolution in enolase superfamily: strategies for assigning functions. J Biol Chem (2011) 1.40

Structural characterization of acylimine-containing blue and red chromophores in mTagBFP and TagRFP fluorescent proteins. Chem Biol (2010) 1.40

Transition state analogs of 5'-methylthioadenosine nucleosidase disrupt quorum sensing. Nat Chem Biol (2009) 1.39

Picomolar transition state analogue inhibitors of human 5'-methylthioadenosine phosphorylase and X-ray structure with MT-immucillin-A. Biochemistry (2004) 1.35

Mapping the G-actin binding surface of cofilin using synchrotron protein footprinting. Biochemistry (2002) 1.33

Gene cluster responsible for validamycin biosynthesis in Streptomyces hygroscopicus subsp. jinggangensis 5008. Appl Environ Microbiol (2005) 1.31

Crystal structure of PTP1B complexed with a potent and selective bidentate inhibitor. J Biol Chem (2003) 1.29

Structure and dynamics of the actin filament. Biochemistry (2005) 1.28

Four generations of transition-state analogues for human purine nucleoside phosphorylase. Proc Natl Acad Sci U S A (2010) 1.28

NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. Immunity (2006) 1.27

Mechanism of the orotidine 5'-monophosphate decarboxylase-catalyzed reaction: evidence for substrate destabilization. Biochemistry (2009) 1.27

Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control. Genes Dev (2012) 1.26

During the early prediabetic period in NOD mice, the pathogenic CD8(+) T-cell population comprises multiple antigenic specificities. Clin Immunol (2002) 1.24

Cofilin (ADF) affects lateral contacts in F-actin. J Mol Biol (2004) 1.24

B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol Lett (2005) 1.24

Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion. Biochemistry (2005) 1.23

At the periphery of the amidohydrolase superfamily: Bh0493 from Bacillus halodurans catalyzes the isomerization of D-galacturonate to D-tagaturonate. Biochemistry (2008) 1.22

Structure-guided discovery of the metabolite carboxy-SAM that modulates tRNA function. Nature (2013) 1.22

Structural mechanisms of costimulation. Nat Immunol (2002) 1.21

Structural biology of cellular machines. Trends Cell Biol (2006) 1.19

S100A4 regulates macrophage chemotaxis. Mol Biol Cell (2010) 1.19

Visualizing the Ca2+-dependent activation of gelsolin by using synchrotron footprinting. Proc Natl Acad Sci U S A (2003) 1.18

Cas5d processes pre-crRNA and is a member of a larger family of CRISPR RNA endonucleases. RNA (2012) 1.18

Photoactivation mechanism of PAmCherry based on crystal structures of the protein in the dark and fluorescent states. Proc Natl Acad Sci U S A (2009) 1.18

Radiation-induced site-specific damage of mercury derivatives: phasing and implications. Acta Crystallogr D Biol Crystallogr (2005) 1.18

A high-affinity interaction with ADP-actin monomers underlies the mechanism and in vivo function of Srv2/cyclase-associated protein. Mol Biol Cell (2004) 1.18

Structural analysis of gelsolin using synchrotron protein footprinting. Mol Cell Proteomics (2003) 1.18

Homology models guide discovery of diverse enzyme specificities among dipeptide epimerases in the enolase superfamily. Proc Natl Acad Sci U S A (2012) 1.17

Structure of CD84 provides insight into SLAM family function. Proc Natl Acad Sci U S A (2007) 1.17

Visualizing Arp2/3 complex activation mediated by binding of ATP and WASp using structural mass spectrometry. Proc Natl Acad Sci U S A (2007) 1.16

Polylysine induces an antiparallel actin dimer that nucleates filament assembly: crystal structure at 3.5-A resolution. J Biol Chem (2002) 1.15

Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proc Natl Acad Sci U S A (2005) 1.15

Transition state analogues in structures of ricin and saporin ribosome-inactivating proteins. Proc Natl Acad Sci U S A (2009) 1.15

Evolution of enzymatic activities in the enolase superfamily: L-talarate/galactarate dehydratase from Salmonella typhimurium LT2. Biochemistry (2007) 1.15

Mechanistic diversity in the RuBisCO superfamily: the "enolase" in the methionine salvage pathway in Geobacillus kaustophilus. Biochemistry (2007) 1.14

How actin crosslinking and bundling proteins cooperate to generate an enhanced cell mechanical response. Biochem Biophys Res Commun (2005) 1.13

Evolution of enzymatic activities in the enolase superfamily: L-rhamnonate dehydratase. Biochemistry (2008) 1.12

Computation-facilitated assignment of the function in the enolase superfamily: a regiochemically distinct galactarate dehydratase from Oceanobacillus iheyensis . Biochemistry (2009) 1.12

Engineering ESPT pathways based on structural analysis of LSSmKate red fluorescent proteins with large Stokes shift. J Am Chem Soc (2010) 1.12

Structure, evolutionary conservation, and conformational dynamics of Homo sapiens fascin-1, an F-actin crosslinking protein. J Mol Biol (2010) 1.12

Evolution of enzymatic activities in the enolase superfamily: D-tartrate dehydratase from Bradyrhizobium japonicum. Biochemistry (2006) 1.11

Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function. Proc Natl Acad Sci U S A (2007) 1.11

The gate that governs sulfotransferase selectivity. Biochemistry (2012) 1.11

Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in a primate animal model. PLoS One (2011) 1.10

Structure of Ca2+-bound S100A4 and its interaction with peptides derived from nonmuscle myosin-IIA. Biochemistry (2008) 1.10

Evolution of enzymatic activities in the enolase superfamily: D-Mannonate dehydratase from Novosphingobium aromaticivorans. Biochemistry (2007) 1.10

Extended Stokes shift in fluorescent proteins: chromophore-protein interactions in a near-infrared TagRFP675 variant. Sci Rep (2013) 1.10

Decoy strategies: the structure of TL1A:DcR3 complex. Structure (2011) 1.10

Sequence, structure, function, immunity: structural genomics of costimulation. Immunol Rev (2009) 1.08

Prediction of function for the polyprenyl transferase subgroup in the isoprenoid synthase superfamily. Proc Natl Acad Sci U S A (2013) 1.06

Evolution of GITRL immune function: murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily. Proc Natl Acad Sci U S A (2008) 1.06

Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling. Proc Natl Acad Sci U S A (2003) 1.06